| |
| |
|
| Insider
Information: |
Ryan Arthur F |
| Relationship: |
Director |
| City: |
Newark |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
384,655 |
|
|
Indirect Shares
|
462 |
|
|
| Direct
Value |
$26,686,150 |
|
|
|
Indirect Value
|
$11,562 |
|
|
| Total
Shares |
385,117 |
|
|
| Total
Value |
$26,697,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 22.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Prudential Financial Inc |
PJH |
Chairman, Director |
2008-02-12 |
265,366 |
2008-02-12 |
462 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-01 |
18,082 |
2010-06-14 |
0 |
Premium* |
|
|
JetPay Corporation |
JTPY |
Director |
2012-12-28 |
40,213 |
|
0 |
Premium* |
|
|
Citizens Financial Group, Inc. |
CFG |
Director |
2019-02-14 |
60,994 |
2014-09-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-01 |
4 |
S |
$145.57 |
$1,455,700 |
D/D |
(10,000) |
40,355 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-06 |
4 |
OE |
$177.82 |
$18,729,670 |
D/D |
50,124 |
78,967 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-08-22 |
4 |
D |
$236.64 |
$956,499 |
D/D |
(4,042) |
60,813 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-08-23 |
4 |
S |
$238.47 |
$2,613,154 |
D/D |
(10,958) |
49,855 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-05-31 |
4 |
S |
$249.45 |
$623,885 |
D/D |
(2,500) |
34,855 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-08-04 |
4 |
OE |
$374.12 |
$4,319,835 |
D/D |
10,453 |
21,092 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2016-05-24 |
4 |
S |
$396.64 |
$396,640 |
D/D |
(1,000) |
39,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-02-20 |
4 |
S |
$421.72 |
$12,372,908 |
D/D |
(29,250) |
47,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2016-11-15 |
4 |
S |
$429.34 |
$858,680 |
D/D |
(2,000) |
36,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-03-30 |
4 |
AS |
$462.80 |
$46,669 |
D/D |
(100) |
29,043 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-04-01 |
4 |
AS |
$477.58 |
$48,385 |
D/D |
(100) |
28,943 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
AS |
$477.58 |
$48,360 |
D/D |
(100) |
23,543 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-02-01 |
4 |
AS |
$504.68 |
$50,692 |
D/D |
(100) |
23,691 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-12-01 |
4 |
AS |
$515.64 |
$52,048 |
D/D |
(100) |
23,643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-01 |
4 |
AS |
$517.41 |
$52,037 |
D/D |
(100) |
28,843 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-06 |
4 |
S |
$541.66 |
$27,612,509 |
D/D |
(50,124) |
28,843 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-11-02 |
4 |
AS |
$544.54 |
$54,854 |
D/D |
(100) |
23,743 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-10-01 |
4 |
AS |
$553.73 |
$55,813 |
D/D |
(100) |
28,343 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-01 |
4 |
AS |
$555.47 |
$56,450 |
D/D |
(100) |
23,491 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-10-01 |
4 |
AS |
$560.51 |
$56,949 |
D/D |
(100) |
23,191 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-02 |
4 |
AS |
$572.94 |
$57,795 |
D/D |
(100) |
23,391 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-06 |
4 |
AS |
$576.85 |
$58,237 |
D/D |
(100) |
19,582 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-09-01 |
4 |
AS |
$591.50 |
$60,458 |
D/D |
(100) |
28,443 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-01 |
4 |
AS |
$598.58 |
$60,323 |
D/D |
(100) |
28,743 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-02-01 |
4 |
AS |
$600.89 |
$60,714 |
D/D |
(100) |
22,482 |
0 |
% |
|
102 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
